Medical Toxicology and COVID-19: Our Role in a Pandemic

J Med Toxicol. 2020 Jul;16(3):245-247. doi: 10.1007/s13181-020-00778-4. Epub 2020 Apr 30.

Natalie R Neumann¹, Peter R Chai^{2

3

4

5}, David M Wood^{6

7}, Howard A Greller⁸, Mark B Mycyk⁹

¹ Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO, 80204, USA. natalie.neumann@cuanschutz.edu.
² Division of Medical Toxicology, Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, USA.
³ Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, MA, USA.
⁴ The Koch Institute for Integrated Cancer Research, Massachusetts Institute of Technology, Boston, MA, USA.
⁵ The Fenway Institute, Boston, MA, USA.
⁶ Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
⁷ Faculty of Life Sciences and Medicine, King's College London, London, UK.
⁸ Division of Medical Toxicology, Department of Emergency Medicine, SBH Health Systems, New York City, NY, USA.
⁹ Department of Emergency Medicine, Cook County Health, Chicago, IL, 60612, USA.

No abstract available

Keywords: COVID-19; Drug-related side effects and adverse reactions; Pandemics; Poisoning; Toxicology.

Publication types